ASCO Annual Meeting

Healio.com brings you the highlights from the ASCO Annual Meeting. Refer back to this page often to read the latest news from ASCO, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Meeting News

Pembrolizumab demonstrates antitumor activity in small cell lung cancer

August 16, 2018
CHICAGO — Pembrolizumab demonstrated “promising” antitumor activity among patients with advanced small-cell lung cancer…
Meeting News

Lymph node collection kit improves outcomes of lung cancer resection

August 15, 2018
CHICAGO — The use of a lymph node specimen collection kit during non-small cell lung cancer resection significantly improved staging quality…
Meeting News

Pembrolizumab lacks efficacy, may be unsafe in NSCLC subgroup

August 14, 2018
CHICAGO — Pembrolizumab failed to demonstrate efficacy in patients with PD-L1-positive, EGFR-mutated advanced non-small cell lung cancer who…
Meeting News

Bevacizumab plus erlotinib improves PFS for non-small cell lung cancer

August 13, 2018
CHICAGO — Phase 3 data from the NEJ026 trial showed that a combination regimen of bevacizumab plus erlotinib prolonged PFS compared with…
Meeting NewsVideo

VIDEO: Novel agent appears safe, effective in metastatic urothelial carcinoma

August 7, 2018
CHICAGO — Docetaxel in combination with the novel agent B-701 appeared safe and effective in patients with locally advanced or metastatic…
Meeting News

New evidence may help improve management of rare kidney cancers

August 7, 2018
CHICAGO — Researchers have identified relapse patterns of nonclear cell renal cell carcinomas — an understudied group of rare kidney…
Meeting NewsVideo

VIDEO: Erdafitinib may be ‘viable option’ for subset of urothelial carcinoma

August 6, 2018
CHICAGO — Erdafitinib induced a robust response among patients with chemotherapy-refractory metastatic or unresectable urothelial carcinoma and…
Meeting News

Atezolizumab shows ‘meaningful’ efficacy against bladder cancer

August 6, 2018
CHICAGO — Phase 2 data from the ABACUS trial showed that neoadjuvant atezolizumab therapy was safe and demonstrated a “meaningful”…
Meeting News

Cytoreductive nephrectomy may still remain standard for some with metastatic renal cell carcinoma

August 4, 2018
CHICAGO — The addition of cytoreductive nephrectomy to treatment with sunitinib malate did not provide a survival benefit for intermediate and…
Meeting News

Dacomitinib improves OS for EGFR-positive lung cancer, may be of limited clinical use

August 3, 2018
CHICAGO — Updated phase 3 data from the ARCHER 1050 trial showed that dacomitinib improved OS compared with gefitinib among patients with newly…